HIFU - Maple Leaf HIFU Co. Medical Offices at Cleveland Clinic Canada
Home Page About HIFU Information for Patients See if you qualify for HIFU Information for Physicians About Maple Leaf HIFU Co. Contact Maple Leaf HIFU Co.

Patient Information

Cancer & the Prostate

Treatments

About Ablatherm® HIFU

Benefits of Ablatherm® HIFU

Ablatherm vs. Sonablate

Your Treatment

Post-Treatment

Potential Complications

Patient Stories

FAQs


US Insurance Reimbursement

Video of HIFU Procedure

HIFU Radio Program

HIFU Payment Plans

2006 HIFU Treatment Technology & Outcome Update
Read the latest clinical data and comparison of HIFU
by John C. Rewcastle, Ph.D.,
University of Calgary

Important Travel Information for U.S. Patients

 

 

Home > Patients > Cancer & the Prostate

Cancer & the Prostate

What is the Prostate?

The prostate is a chestnut shaped gland surrounding the beginning of the urethra in the male. It varies in size according to the patient's age. It is located under the bladder in front of the rectum. Contrary to many generally accepted ideas the prostate is not linked to sexual desire or related to the mechanisms of erection. In fact, the function of the prostate gland is to produce the major part of the seminal fluid which is used as a means of transportation of sperm.


What is Cancer?

Normal cells in the body are constantly dividing, maturing and then dying in a tightly controlled process. Cells are called cancerous when their growth is no longer well-regulated. Instead of dying, as they should, cancer cells outlive normal cells and continue to form new, abnormal cells. Abnormal cell growths are called tumors. Prostate cancer occurs when cells within the prostate grow uncontrollably, creating small tumors. Prostate cancer is typically comprised of multiple, very small tumors within the prostate. When the tumors are confined to the prostate the disease is often curable (rates of 90% or better) using interventions such as surgery or Ablatherm® HIFU that aim to remove or kill all cancerous cells in the prostate. Signs and symptoms are usually not evident in the early stages of prostate cancer.

How Common is Prostate Cancer?

Prostate cancer is the leading cancer among men in the USA and the second most common malignancy in males worldwide after lung cancer. It is estimated that 38.7 million men in North America, Europe and Japan have prostate cancer. Incidence varies in different countries. A low of 3.5 per 100,000 new cases occur annually in Singapore while approximately 240,000 new cases of cancer of the prostate are diagnosed each year in the United States.

How is Prostate Cancer Diagnosed?

The only way to confirm the diagnosis of prostate cancer is to perform a biopsy.

Once a definite diagnosis of cancer has been made the next step is to know what the cancer's stage is. This cancer staging helps determine which treatment will work the best. There are 3 basic stages of Prostate Cancer:

  • Early stage cancer confined to the prostate (T-1, T-2)

  • Locally advanced cancer extending beyond the prostate (T-3)

  • Metastatic cancer which has spread to other organs such as lymph nodes or bones (T-4)

Ablatherm® HIFU is only recommended for treatment of the early stage cancer confined to the prostate gland (T-1 and T-2).

 

Next Topic: Prostate Cancer Treatments